Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?

Journal of Business Ethics 94 (2):211-224 (2010)
Abstract
Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America and the European Union (EU). Doing so results in an alternative analysis of the struggle between proponents and opponents of DTCA from a CSR perspective, adding an alternative view on this debate
Keywords corporate social responsibility (CSR)  pharmaceutical industry  direct-to-consumer-advertising (DTCA)  consumer safety
Categories (categorize this paper)
Options
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
 
Download options
PhilPapers Archive


Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 9,351
External links
  •   Try with proxy.
  • Through your library Configure
    References found in this work BETA

    View all 9 references

    Citations of this work BETA
    Similar books and articles
    Analytics

    Monthly downloads

    Added to index

    2009-11-23

    Total downloads

    28 ( #52,550 of 1,088,370 )

    Recent downloads (6 months)

    1 ( #69,449 of 1,088,370 )

    How can I increase my downloads?

    My notes
    Sign in to use this feature


    Discussion
    Start a new thread
    Order:
    There  are no threads in this forum
    Nothing in this forum yet.